Henningfield, Caden M.
Soni, Neelakshi
Lee, Ryan W.
Sharma, Rishi
Cleland, Jeffrey L.
Green, Kim N.
Funding for this research was provided by:
National Institute on Aging (F31AG072852, R01AG056768)
National Institute of Neurological Disorders and Stroke (R01NS083801)
Article History
Received: 26 October 2023
Accepted: 29 April 2024
First Online: 6 May 2024
Declaration
:
: The present study and associated protocols were approved by the UC Irvine Institutional Animal Care and Use Committee (IACUC) and were compliant with ethical regulations for animal research and testing.
: Not applicable.
: KNG is on the scientific advisory board of Ashvattha Therapeutic Inc. Jeffrey Cleland is President and CEO of Ashvattha Therapeutic Inc. Rishi Sharma was a full-time employee of Ashvattha Therapeutic Inc. All other authors declare no competing interests.